Skip to content

Medical-device intelligence

DJP: Radioimmunoassay, Amphetamine

FDA product code DJP: Radioimmunoassay, Amphetamine. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
DJP
FDA device name
Radioimmunoassay, Amphetamine
Device class
2
Regulation number
862.3100
Medical specialty
Clinical Toxicology
Review panel
TX

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical toxicology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

9 clearance records and 0 recall records in the covered releases, across 5 source company names and 1 product codes. Dated history runs from Jan 22, 1982 to Mar 18, 1996.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
DJP · Radioimmunoassay, Amphetamine90

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

9 matching records
Device / recordCompany in FDA recordSourceSource date
PRIMIDONE EIA TESTK960526 · DJPDiagnostic Reagents, Inc.510(k)Mar 18, 1996FDA decision date
URINE AMPHETAMINE DIRECT RIA KIT (I-125)K913866 · DJPImmunalysis Corporation510(k)Sep 25, 1991FDA decision date
ABUSCREEN RADIOIMMUNOASSAY FOR AMPHETAMINEK912755 · DJPRoche Diagnostic Systems, Inc.510(k)Aug 26, 1991FDA decision date
REVISED DOUBLE ANTIBODY AMPHETAMINEK882228 · DJPDiagnostic Products Corp.510(k)Aug 8, 1988FDA decision date
ABUSCREEN(R) ONTRAK(TM) FOR AMPHETAMINESK881817 · DJPRoche Diagnostic Systems, Inc.510(k)Jul 29, 1988FDA decision date
ABUSCREEN RADIOIMMUNOASSAY FOR AMPHETAMINE-HIGH SPK854009 · DJPRoche Diagnostic Systems, Inc.510(k)Oct 15, 1985FDA decision date
ABUSCREEN RADIOIMMUNOASSAY-AMPHETAMINEK830482 · DJPHoffmann-La Roche, Inc.510(k)Mar 24, 1983FDA decision date
ABUSCREEN RADIOIMMUNOASSAY - AMPHETAMINEK823212 · DJPHoffmann-La Roche, Inc.510(k)Nov 29, 1982FDA decision date
AGGLUTEX AMPHETAMINE TEST KITK812986 · DJPHoffmann-La Roche, Inc.510(k)Jan 22, 1982FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗